Skip to content

Arm More + Camp: An Implementation Study

Arm More + Camp: An Implementation Study of a Modified Constraint Induced Movement Therapy Camp for Children With Hemiparesis

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07065916
Enrollment
40
Registered
2025-07-15
Start date
2025-07-09
Completion date
2026-12-31
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Brain Injury (Including Stroke), Cerebral Palsy Spastic Hemiplegic, Hemiplegia

Keywords

Cerebral palsy, Constraint induced movement therapy, Bimanual therapy, Hemiplegia

Brief summary

Our primary aim is to evaluate the implementation cost of a full day modified constraint induced movement therapy camp for children with hemiparesis. Participants will complete a day camp (9am to 4pm) with constraint induced movement therapy in Week 1 and bimanual therapy in Week 2.

Interventions

Constraint Induced Movement Therapy and Bimanual Therapy

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Mild to moderate hemiparesis due to cerebral palsy or acquired brain injury (e.g, traumatic brain injury, stroke) * Ability to actively extend wrist to neutral and actively flex and extend fingers (at minimum) * Attend school full-time * Able to participate in group activities * Written consent

Exclusion criteria

* Severe hemiparesis due to cerebral palsy or acquired brain injury * No wrist movement on the hemiplegic hand. * Unable to concentrate for periods of 60-90minutes

Design outcomes

Primary

MeasureTime frameDescription
Implementation CostFrom enrolment to the end of outcome data collection at 3 weeksImplementation cost covers all resources necessary, including personnel, time, space, and supplies.

Secondary

MeasureTime frame
Canadian Occupational Performance MeasureBaseline and the end of treatment at 2 weeks

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026